CFGI Announces Appointment of Jay Clayton to Board of Directors

BOSTON, 2024—CFGI, a leading global accounting and business advisory firm and a portfolio company of The Carlyle Group and CVC Capital Partners, is pleased to announce the addition of Walter “Jay” Clayton as an independent member of its Board of Directors, effective immediately.

More

Gappify and CFGI Announce Strategic Partnership

BOSTON, Aug.

More

CFGI Announces Expansion Into the UK

LONDON, July 26, 2023 — CFGI, a portfolio company of Carlyle and CVC, announces its expansion into the U.

More

Oculis Announces Public Listing After Completing Business Combination Between European Biotech Acquisition Corp. And Oculis SA

CFGI’s Capital Markets team assisted Oculis Holding AG (“Oculis”) with its listing on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Third Harmonic Bio Closes Upsized Initial Public Offering of Shares of Common Stock Trading on the NASDAQ Global Market

CFGI’s Life Sciences team assisted Third Harmonic Bio (NASDAQ: THRD) with their initial public offering.

More

Senti Biosciences Completes Merger With Dynamics Special Purpose Corp.

CFGI’s Capital Markets team assisted Senti Biosciences, Incorporated (“Senti Bio”) with the completion of its merger with Dynamics Special Purpose Corporation (“DYNS”) (Nasdaq: DYNS), a special purpose acquisition company.

More

BCP Raptor Holdco LP Completes Reverse Merger With Altus Midstream Company

CFGI’s Capital Markets team assisted privately-owned BCP Raptor Holdco LP (“BCP”), the parent company of EagleClaw Midstream, with the completion of an all-stock business combination with Altus Midstream Company (Nasdaq: ALTM) (“Altus”), creating a unique, fully-integrated midstream company.

More

2021 Year in Review

2021 was a year of tremendous change and growth for CFGI.

More